7 novembre, 2006 11:49

UPDATE 1-Mentor reports higher quarterly profit- silicone breast implants

Mentor Corp.,which is awaiting final U.S. approval to resume widespread sales of its silicone breast implants, on Monday reported a higher quarterly profit, helped by strong sales of breast and facial products.

The Santa Barbara, California-based company posted a net profit from continuing operations of $10.8 million, or 24 cents per share, for its fiscal second quarter ended Sept. 30, compared with $8.2 million, or 17 cents per share, a year ago.

Excluding items, Mentor earned 31 cents per share from continuing operations. Analysts on average were expecting 24 cents per share, according to Reuters Estimates.

Mentor said it expects fiscal 2007 sales of $290 million to $305 million, but noted that the forecast does not include the impact of potential U.S. approval for its silicone gel breast implants.

Wall Street is estimating 2007 sales of $299 million.

The company also expects to record a charge of 16 cents to 17 cents per share in 2007 to account for stock-based compensation.

Sales rose 14 percent to $66.9 million for the second quarter, topping Wall Street expectations of $64.7 million.

We, haven't been told there's a vote planned as finally approval for, Mentor's faultly implants. Since; Mentor hasn't submitted the correct data to the FDA. If, you haven't submitted a Med Watch form; or amended it do so right away off your computer. I, amended; mine again this week and contacted my congressperson, reps, senators Concerning this issue. Mentor an Inamed, have not complied with the rules the; FDA set forth for the studies on these new toxic new gummy bear implant studies.

There Are, women ill from these new gummy bear gel implants by; Mentor an Inamed.

GiGI